Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint InhibitorsAdam J. Schoenfeld, Kai He, Simon Häfliger et al.|Cancer Discovery|2024Cited by 108
BO-112 Plus Pembrolizumab for Patients With Anti–PD-1–Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203Iván Márquez‐Rodas, Stéphane Dalle, Caroline Dutriaux et al.|Journal of Clinical Oncology|2025Cited by 7